The announcement
NVIDIA announced on October 21, 2026 that it is working with supply-chain partners to expand manufacturing capacity for accelerated-computing and AI-factory products. The company said substrate capacity is targeted to increase 2.5 times over the next three years, while Amkor plans to increase advanced-packaging capacity by more than 300% by the end of 2028.
The capital signal
NVIDIA also disclosed a $1.1 billion capacity-reservation advance to KYEC to support new U.S. testing facilities and equipment. That is not an equity offering and should not be described as dilution. It is a capital-allocation and supply-assurance commitment: NVIDIA is using its balance sheet to help secure future production capacity.
What dilution investors should watch
- Share-based compensation: monitor dilution from employee awards separately from supplier commitments.
- Cash deployment: distinguish capacity advances, acquisitions, and capital expenditures from recurring operating costs.
- Supplier concentration: follow whether expansion actually creates redundancy or merely scales dependence on a few critical partners.
- Demand conversion: capacity growth is not revenue growth until customers take delivery and pay.
Bottom line
NVIDIA’s supply-chain announcement is a growth-capacity story, not a dilution event. For a shareholder, the key issue is whether the company can convert large ecosystem investments into durable revenue and cash flow while keeping share-based compensation and other equity issuance under control.